There exists a critical need for new therapeutic approaches to treat ischemic cardiovascular diseases, and neovascularization will likely be a critical component of these therapies While most pre-clinical and clinical efforts to promote neovascularization in cardiovascular diseases have focused on bolus delivery of proangiogenic growth factors, these approaches may be limited by potential side-effects and the inability of single growth factors to promote the formation of a mature and stable vasculature. The hypothesis underlying this proposal is that one may rapidly promote the formation of mature vascular network in an ischemic lower limb by the localized delivery of an appropriate combination of blood-vessel forming cells and growth factors using biodegradable polymer carriers. This hypothesis will be addressed by fabricating three-dimensional porous scaffolds from poly (lactide-co-glycolide) (PLG) that are capable of the localized and sustained delivery of combinations and sequences of angiogenic molecules (vascular endothelial growth factor [VEGF], platelet derived growth factor [PDGF], and transforming growth factor-beta [TGF-beta). Neovascularization induced from sustained delivery of each factor alone, as contrasted with combination or sequential delivery of the factors will be analyzed in a subcutaneous mouse implant model. Secondly, the ability of differentiated endothelial cells and endothelial cell precursors, both mouse and human-derived, to form new networks of blood vessels and integrate with host vasculature will be evaluated following pre-culture and implantation using the 3-D porous scaffolds. Finally, these cell types will be transplanted into ischemic hind limbs of mice using scaffolds releasing the combination of growth factors found to lead to optimal host vascular cell response. In these last studies, mice that mimic human critical limb ischemia will be utilized. Successful completion of these studies may lead to new approaches in therapeutic angiogenesis (e.g., delivery of combinations of growth factors and blood vessel forming cells). In addition, the systems developed in these studies may provide novel and important model systems to study a variety of developmental processes dependent on the signaling of multiple growth factors.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL069957-03
Application #
6952302
Study Section
Surgery and Bioengineering Study Section (SB)
Program Officer
Lundberg, Martha
Project Start
2003-09-15
Project End
2007-08-31
Budget Start
2005-09-01
Budget End
2006-08-31
Support Year
3
Fiscal Year
2005
Total Cost
$481,520
Indirect Cost
Name
Harvard University
Department
Engineering (All Types)
Type
Schools of Arts and Sciences
DUNS #
082359691
City
Cambridge
State
MA
Country
United States
Zip Code
02138
Anderson, Erin M; Silva, Eduardo A; Hao, Yibai et al. (2017) VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits. J Vasc Res 54:288-298
Anderson, Erin M; Mooney, David J (2015) The Combination of Vascular Endothelial Growth Factor and Stromal Cell-Derived Factor Induces Superior Angiogenic Sprouting by Outgrowth Endothelial Cells. J Vasc Res 52:62-9
Kwee, Brian J; Mooney, David J (2015) Manipulating the intersection of angiogenesis and inflammation. Ann Biomed Eng 43:628-40
Anderson, Erin M; Kwee, Brian J; Lewin, Sarah A et al. (2015) Local delivery of VEGF and SDF enhances endothelial progenitor cell recruitment and resultant recovery from ischemia. Tissue Eng Part A 21:1217-27
Schmidt-Bleek, Katharina; Kwee, Brian J; Mooney, David J et al. (2015) Boon and Bane of Inflammation in Bone Tissue Regeneration and Its Link with Angiogenesis. Tissue Eng Part B Rev 21:354-64
Roche, Ellen T; Hastings, Conn L; Lewin, Sarah A et al. (2014) Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. Biomaterials 35:6850-6858
Silva, Eduardo A; Eseonu, Chikezie; Mooney, David J (2014) Endothelial cells expressing low levels of CD143 (ACE) exhibit enhanced sprouting and potency in relieving tissue ischemia. Angiogenesis 17:617-30
Kaigler, Darnell; Silva, Eduardo A; Mooney, David J (2013) Guided bone regeneration using injectable vascular endothelial growth factor delivery gel. J Periodontol 84:230-8
Brudno, Yevgeny; Ennett-Shepard, Alessandra B; Chen, Ruth R et al. (2013) Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. Biomaterials 34:9201-9
Shamis, Yulia; Silva, Eduardo A; Hewitt, Kyle J et al. (2013) Fibroblasts derived from human pluripotent stem cells activate angiogenic responses in vitro and in vivo. PLoS One 8:e83755

Showing the most recent 10 out of 40 publications